NDC Pharmacologic Class N0000175621 Interleukin 2 Receptor-directed Antibody Interactions [MoA]

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
0074-0033Zinbryta DaclizumabInjection, SolutionSubcutaneousAbbvieHuman Prescription Drug
0074-0034Zinbryta PenDaclizumabInjection, SolutionSubcutaneousAbbvieHuman Prescription Drug
0078-0331Simulect BasiliximabInjection, Powder, For SolutionIntravenousNovartis Pharmaceuticals CorporationHuman Prescription Drug
0078-0393Simulect BasiliximabInjection, Powder, For SolutionIntravenousNovartis Pharmaceuticals CorporationHuman Prescription Drug

There are 4 NDC products with the pharmacologic class Interleukin 2 Receptor-directed Antibody Interactions [MoA].